Literature DB >> 12547912

Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells.

Neeltje A Kootstra1, Carsten Munk, Nina Tonnu, Nathaniel R Landau, Inder M Verma.   

Abstract

HIV-1 replication in simian cells is restricted at an early postentry step because of the presence of an inhibitory cellular factor. This block reduces the usefulness of HIV-1-based lentiviral vectors in primate animal models. Here, we demonstrate that substitution of the cyclophilin A (CyPA) binding region in the capsid of an HIV-1-based lentiviral vector (LV) with that of the macrophage tropic HIV-1 Ba-L resulted in a vector that was resistant to the inhibitory effect and efficiently transduced simian cells. Notably, the chimeric gag LV efficiently transduced primary simian hematopoietic progenitor cells, a critical cellular target in gene therapy. The alterations in the CyPA binding region did not affect CyPA incorporation; however, transduction by the gag chimeric LV seemed to be relatively insensitive to cyclosporin A, indicating that it does not require CyPA for early postentry steps. In dual infection experiments, the gag chimeric LV failed to remove the block to transduction of the WT LV, suggesting that the gag chimeric LV did not saturate the inhibitory simian cellular factor. These data suggest that the CyPA binding region of capsid contains a viral determinant involved in the postentry restriction of HIV-1-based lentiviral vectors. Overall, the findings demonstrate that the host range of HIV-1-based LV can be altered by modifications in the packaging construct.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12547912      PMCID: PMC298767          DOI: 10.1073/pnas.0337541100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  HIV-1 genome nuclear import is mediated by a central DNA flap.

Authors:  V Zennou; C Petit; D Guetard; U Nerhbass; L Montagnier; P Charneau
Journal:  Cell       Date:  2000-04-14       Impact factor: 41.582

2.  HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress.

Authors:  J Martin-Serrano; T Zang; P D Bieniasz
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

3.  Abrogation of Ref1 retrovirus restriction in human cells.

Authors:  Greg Towers; Mary Collins; Yasuhiro Takeuchi
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.

Authors:  J E Garrus; U K von Schwedler; O W Pornillos; S G Morham; K H Zavitz; H E Wang; D A Wettstein; K M Stray; M Côté; R L Rich; D G Myszka; W I Sundquist
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

5.  A conserved mechanism of retrovirus restriction in mammals.

Authors:  G Towers; M Bock; S Martin; Y Takeuchi; J P Stoye; O Danos
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

6.  Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.

Authors:  Dimiter G Demirov; Akira Ono; Jan M Orenstein; Eric O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

7.  Differential dependence of the infectivity of HIV-1 group O isolates on the cellular protein cyclophilin A.

Authors:  Klaus Wiegers; Hans-Georg Kräusslich
Journal:  Virology       Date:  2002-03-15       Impact factor: 3.616

8.  Species-specific, postentry barriers to primate immunodeficiency virus infection.

Authors:  W Hofmann; D Schubert; J LaBonte; L Munson; S Gibson; J Scammell; P Ferrigno; J Sodroski
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

9.  The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811.

Authors:  T Dorfman; H G Göttlinger
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

10.  Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences.

Authors:  A Follenzi; L E Ailles; S Bakovic; M Geuna; L Naldini
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

View more
  84 in total

1.  Identification of synthetic endothelial cell-specific promoters by use of a high-throughput screen.

Authors:  Christine Dai; Robin E McAninch; Richard E Sutton
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Retroviral capsid determinants of Fv1 NB and NR tropism.

Authors:  Anthony Stevens; Michael Bock; Scott Ellis; Paul LeTissier; Kate N Bishop; Melvyn W Yap; Willie Taylor; Jonathan P Stoye
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  Retroviral restriction factor TRIM5alpha is a trimer.

Authors:  Claudia C Mische; Hassan Javanbakht; Byeongwoon Song; Felipe Diaz-Griffero; Matthew Stremlau; Bettina Strack; Zhihai Si; Joseph Sodroski
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 4.  Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection.

Authors:  Jeremy Luban
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

5.  Structural requirements for recognition of the human immunodeficiency virus type 1 core during host restriction in owl monkey cells.

Authors:  Brett M Forshey; Jiong Shi; Christopher Aiken
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor.

Authors:  Matthew Stremlau; Michel Perron; Mark Lee; Yuan Li; Byeongwoon Song; Hassan Javanbakht; Felipe Diaz-Griffero; Donovan J Anderson; Wesley I Sundquist; Joseph Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-15       Impact factor: 11.205

Review 7.  Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models.

Authors:  Andre Larochelle; Cynthia E Dunbar
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

8.  Analysis of human cell heterokaryons demonstrates that target cell restriction of cyclosporine-resistant human immunodeficiency virus type 1 mutants is genetically dominant.

Authors:  Chisu Song; Christopher Aiken
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

9.  Evidence for a different susceptibility of primate lentiviruses to type I interferons.

Authors:  Stéphanie Cordeil; Xuan-Nhi Nguyen; Gregory Berger; Stéphanie Durand; Michelle Ainouze; Andrea Cimarelli
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

10.  Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.

Authors:  Theodora Hatziioannou; David Perez-Caballero; Annie Yang; Simone Cowan; Paul D Bieniasz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.